Osteoporosis can be meaningfully improved, and in some cases partly reversed, through the right combination of medications, weight-bearing exercise, and targeted nutrition. The condition stems from an imbalance where bone is broken down faster than it is rebuilt, and every effective strategy works by tipping that balance back toward formation or slowing the rate of loss. No single approach works as well alone as a combination does, and the specifics matter: the wrong type of exercise, the wrong calcium supplement, or a medication stopped at the wrong time can each make things worse rather than better.
What Is Actually Happening Inside Your Bones
Your skeleton is not a static scaffold. It is constantly remodeling: specialized cells called osteoclasts dissolve old bone, and osteoblasts lay down new bone in its place. In healthy adults, these two processes stay roughly in balance. Osteoporosis develops when osteoclast activity outpaces osteoblast activity, driven by a signaling pathway known as the RANK-RANKL-OPG axis.1PubMed. Binding-induced fibrillogenesis peptide inhibits RANKL-mediated osteoclast activation against osteoporosis That imbalance accelerates after menopause, during prolonged steroid use, and in several other situations. Understanding this basic tug-of-war matters because every medication, exercise protocol, and dietary choice described below works by nudging one side or the other.
Medications That Slow Bone Loss
The most widely prescribed osteoporosis drugs are antiresorptives, which work by putting the brakes on osteoclasts. The two main classes are bisphosphonates and denosumab, and they act through very different mechanisms. Bisphosphonates (alendronate, risedronate, ibandronate, zoledronic acid) bind directly to the mineral surface of bone and are absorbed by mature osteoclasts, triggering those cells to die off. Denosumab, given as an injection every six months, takes a different route: it blocks the RANKL signal that osteoclasts need to mature and survive in the first place.2PubMed Central. Denosumab: mechanism of action and clinical outcomes In large clinical trials, denosumab reduced vertebral, non-vertebral, and hip fractures compared with placebo and increased bone mineral density (BMD) more than alendronate.3Bone. Denosumab and bisphosphonates: Different mechanisms of action and effects
Your doctor’s choice between the two depends partly on your fracture risk and partly on how long you are likely to stay on treatment. Bisphosphonates linger in bone for years after you stop taking them, which provides a degree of residual protection. Denosumab does not stick around. Stopping it triggers a rebound surge in bone turnover that can erase the density you gained, and in the worst cases, spontaneous vertebral fractures have occurred.4PubMed Central. Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures That means if you start denosumab, you need a clear plan for transitioning to another therapy rather than simply stopping.
Medications That Build New Bone
Antiresorptives slow the loss, but anabolic therapies actively stimulate new bone formation. Three are currently available: teriparatide and abaloparatide, which mimic parathyroid hormone and push bone remodeling in a formation-heavy direction, and romosozumab, an antibody that blocks sclerostin and has a dual effect of boosting formation while also reducing resorption.5PubMed Central. Anabolic therapy for osteoporosis: update on efficacy and safety These drugs can produce striking gains in BMD. In one study, men treated with parathyroid hormone saw their average lumbar spine T-score improve from roughly −3.5 to −2.4, moving from the osteoporosis range toward osteopenia.6The Journal of Clinical Endocrinology & Metabolism. Parathyroid Hormone as a Therapy for Idiopathic Osteoporosis in Men: Effects on Bone Mineral Density and Bone Markers
There is a catch: the bone-building effects are not indefinite. The anabolic signal wanes over time, which is why these therapies are typically limited to one to two years.7PubMed Central. Mechanisms underlying the waning of osteoanabolic therapy effects in osteoporosis After an anabolic course ends, patients are usually transitioned to an antiresorptive to lock in the gains. The sequencing matters: starting with an anabolic and following with an antiresorptive tends to produce better long-term outcomes than the reverse order, a point that has shifted clinical thinking over the past decade.
Long-Term Medication Risks Worth Knowing About
Two rare but serious complications have drawn attention: atypical femoral fractures (unusual breaks in the thigh bone shaft) and osteonecrosis of the jaw (exposed, dying jawbone tissue). Both have been linked to long-term bisphosphonate use, and jaw osteonecrosis has also been reported with high-dose denosumab.8PubMed. Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw The mechanisms behind each appear to differ. Atypical fractures may relate to changes in bone material properties from prolonged low turnover, while jaw osteonecrosis seems tied to infection, often after dental procedures, in bone whose turnover has been suppressed.
A large drug-safety study analyzing over 230,000 patient reports found that the risk varied considerably among individual bisphosphonates. Alendronate patients showed roughly double the risk of both complications compared to denosumab patients, and risedronate was associated with more than a six-fold increase in atypical fracture risk. Zoledronic acid, interestingly, showed lower risk of both side effects compared to denosumab.9PubMed Central. Variable association of atypical femur fracture and osteonecrosis of jaw with bisphosphonates and denosumab use These risks are genuinely rare for most patients, but they are worth discussing with your doctor, especially if you have been on a bisphosphonate for five years or more. Drug holidays, where treatment is paused for a period, are one strategy clinicians use to manage this concern.
Exercise That Actually Strengthens Bone
Not all exercise is equal when it comes to bone. Walking, swimming, and cycling are great for cardiovascular health, but bones respond to stress. They need high-magnitude loading, meaning forces well above what gravity provides during everyday movement, to trigger the remodeling process in the direction of new bone formation. A systematic review of exercise in postmenopausal women found that resistance training and high-impact exercises like jumping were the most effective at improving or maintaining BMD in the lumbar spine and femur.10PubMed Central. The Role of High-intensity and High-impact Exercises in Improving Bone Health in Postmenopausal Women: A Systematic Review
The LIFTMOR trial provides especially encouraging results. Postmenopausal women with osteopenia or osteoporosis were assigned to either a high-intensity resistance and impact training program or a low-intensity home exercise control. After eight months, the high-intensity group gained about 3% in lumbar spine BMD while the control group lost about 1%, a clinically meaningful difference. Femoral neck BMD, height, and functional performance all favored the training group. Compliance was over 90%, and only one minor adverse event (a lower back spasm that resolved quickly) was reported.11PubMed. High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical Function in Postmenopausal Women With Osteopenia and Osteoporosis: The LIFTMOR Randomized Controlled Trial The key detail: this was done under close professional supervision. High-intensity training with osteoporosis requires proper form and progression. Jumping into deadlifts and box jumps without guidance is asking for trouble.
Exercises to Avoid or Modify
Loaded spinal flexion, where you round your spine under load, is consistently flagged as a risk for people with low bone mass. A case series documented vertebral compression fractures in patients with osteopenia who performed certain yoga positions involving extreme spinal flexion.12PubMed. Yoga spinal flexion positions and vertebral compression fracture in osteopenia or osteoporosis of spine: case series The issue is the torque applied to already-weakened vertebral bodies. This does not mean yoga is off limits entirely, but positions like deep forward folds and certain twists need modification or elimination. The Exercise and Sports Science Australia position statement reinforces this: loaded spine flexion is not recommended, and impact activities may need to be adapted for people with osteoarthritis or frailty.13PubMed. Exercise and Sports Science Australia position statement on exercise prescription for the prevention and management of osteoporosis
The practical takeaway: exercises that load the spine in extension or neutral (squats, deadlifts with a flat back, overhead presses) tend to be bone-friendly; exercises that round the spine under load (sit-ups, toe touches with weight, certain Pilates movements) should be approached with extreme caution or skipped.
Balance Training and Fall Prevention
Half the battle with osteoporosis is not just building bone but avoiding the falls that lead to fractures. A meta-analysis of 24 randomized controlled trials found that Tai Chi reduced the risk of falls in older adults by about 24%, and the benefits extended to both healthy older adults and those already at high risk of falling. The effect increased with longer and more frequent practice.14PubMed Central. Tai Chi for fall prevention and balance improvement in older adults: a systematic review and meta-analysis of randomized controlled trials Tai Chi also improved balance on functional tests like the timed up-and-go and single-leg stand.15PubMed Central. Effectiveness of Tai Chi exercise on balance, falls, and motor function in older adults: a meta-analysis
Tai Chi is not the only option. Any structured balance program, including simple exercises like single-leg stands, heel-to-toe walking, and tandem stance holds, helps if done consistently. The point is that preventing fractures involves two fronts: stronger bones and fewer falls. An ideal routine combines resistance training for bone density with balance work for stability.
Calcium and Vitamin D: Getting the Details Right
Calcium and vitamin D are the nutritional bedrock of any osteoporosis plan, but the form and timing of calcium matter more than most people realize. If you take a calcium supplement, the two main options are calcium carbonate and calcium citrate. A meta-analysis found that calcium citrate is absorbed roughly 22% to 27% better than calcium carbonate, whether taken with food or on an empty stomach.16PubMed. Meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate Calcium carbonate is cheaper and more widely available but needs stomach acid to dissolve, so it should be taken with meals. Calcium citrate is the better choice if you take acid-reducing medications or prefer not to tie supplements to eating schedules.
Splitting your calcium dose also helps. Your gut can only absorb about 500 mg at a time efficiently, so taking 1,000 mg in one go wastes a large portion. Two 500 mg doses, spaced several hours apart, is the more effective strategy. And food sources, including dairy, fortified plant milks, canned sardines with bones, and leafy greens like kale, deliver calcium in a matrix that may enhance absorption compared to isolated supplements.
Vitamin D’s role is to facilitate calcium absorption from the gut. Without adequate vitamin D, you could be swallowing calcium supplements for nothing. Blood levels of 25-hydroxyvitamin D in the range often recommended for bone health (generally above 30 ng/mL, though expert opinions vary) typically require supplementation for people who get limited sun exposure, which includes most older adults in northern latitudes.
Vitamin K, Protein, and the Gut-Bone Connection
Vitamin D does not work in isolation. It promotes the production of proteins that require vitamin K to become fully functional. A review of the interplay between the two vitamins found that taking D and K together may be more effective for bone health than either alone.17PubMed Central. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review Vitamin K2 (found in fermented foods, egg yolks, and some cheeses) is the form most studied for bone specifically. It helps direct calcium into bone and away from arteries, where it would contribute to vascular calcification.
Protein’s relationship with bone is less straightforward. Higher protein intake raises IGF-1, a growth factor involved in bone formation. In a two-year trial, women receiving extra whey protein showed significantly higher IGF-1 levels.18Journal of Bone and Mineral Research. The effects of a two‐year randomized, controlled trial of whey protein supplementation on bone structure, IGF‐1, and urinary calcium excretion in older postmenopausal women But an observational study found that higher protein intake was actually associated with lower BMD at the femoral neck and lumbar spine, though the negative association was weakened in women who were physically active.19PubMed Central. Association of Protein Intake with Bone Mineral Density and Bone Mineral Content among Elderly Women: The OSTPRE Fracture Prevention Study The likely explanation: protein by itself is not enough. It needs to be paired with exercise and adequate calcium to translate into bone benefits rather than increased calcium losses through urine.
An emerging area of research is the gut-bone axis. Short-chain fatty acids, produced when gut bacteria ferment dietary fiber, appear to directly regulate osteoclast activity. In mice, both supplementation with short-chain fatty acids and a high-fiber diet significantly increased bone mass and prevented bone loss from estrogen depletion or inflammation. The mechanism involved reprogramming osteoclast metabolism, effectively reducing their ability to break down bone.20Nature Communications. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss This is still mostly animal research, but it suggests that a fiber-rich diet may support bone health through a pathway entirely separate from calcium and vitamin D.
Does Exercise Add Anything on Top of Medication?
This is the question many patients ask: if they are already on a bisphosphonate or denosumab, does exercise provide additional benefit? A systematic review and meta-analysis looked at exactly this. The average effect sizes did favor combining exercise with medication for improving BMD, but the confidence intervals were wide and the evidence quality was very low. No results were found for actual fracture outcomes.21PubMed Central. Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? In other words, the trend looks promising, but the research has not yet proven that exercise on top of drugs produces measurably fewer fractures. That said, exercise offers benefits that medications cannot: improved muscle strength, better balance, and fall prevention. Even if the bone-density effect is modest on top of drugs, the fracture prevention from not falling is real and substantial.
When Osteoporosis Has an Underlying Cause
Before committing to any treatment plan, it is important to rule out secondary causes of bone loss, because treating the underlying condition can itself reverse bone density decline. Glucocorticoid therapy (prednisone and similar drugs) is the most common cause of secondary osteoporosis. The degree of bone loss is directly proportional to the dose and duration of steroid use, and the risk of both vertebral and non-vertebral fractures rises even at low doses.22PubMed. A comprehensive review on glucocorticoids induced osteoporosis: A medication caused disease If you need long-term steroids, preventive treatment with bisphosphonates or denosumab should be discussed early.
Celiac disease is another culprit that flies under the radar. Roughly 30% to 60% of newly diagnosed celiac patients have low BMD, and about 18% to 35% already meet the criteria for osteoporosis at diagnosis, largely because of calcium and vitamin D malabsorption plus chronic inflammation.23PubMed Central. Osteoporosis and Celiac Disease: Updates and Hidden Pitfalls For these patients, a strict gluten-free diet can dramatically improve nutrient absorption and allow bone recovery, sometimes without any osteoporosis-specific medication. Low testosterone in men is yet another secondary cause: men treated with testosterone replacement over six years showed progressive and significant improvement in T-scores.24PubMed Central. Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years
Osteoporosis in Men
Osteoporosis is often treated as a women’s disease, but the literature tells a different story. Fragility fractures occur at a high rate in men, and the risk of dying from a hip fracture is actually higher in men than in women.25PubMed Central. Osteoporosis in Men: A Review of an Underestimated Bone Condition Despite this, men are dramatically underscreened and undertreated. A study of older men with fractures found that only about 7% received any osteoporosis medication after their fracture, and bone density testing was almost non-existent: just over 1% had a DXA scan.26PubMed. The near absence of osteoporosis treatment in older men with fractures If you are a man over 70, or a man of any age with a fragility fracture, steroid use, or low testosterone, asking your doctor for a bone density scan is reasonable and warranted.
How Progress Is Measured
The gold standard for diagnosing osteoporosis and tracking treatment is dual-energy X-ray absorptiometry (DXA), which measures bone mineral density and expresses it as a T-score by comparing your density to that of a healthy young reference population.27PubMed. Use of dual-energy X-ray absorptiometry (DXA) for diagnosis and fracture risk assessment Your DXA result can also be entered into fracture risk calculators like FRAX, which estimates your 10-year probability of a major fracture and helps clinicians decide whether to begin treatment.28PubMed Central. An overview of the use of the fracture risk assessment tool (FRAX) in osteoporosis
Blood tests called bone turnover markers can theoretically detect a response to medication within a few months, far earlier than a DXA can show changes. But current commercial assays are not precise enough to reliably distinguish someone who is responding well from someone who is not. Until assay precision improves and better cutoff values are established, bone turnover markers remain a supplementary tool rather than a replacement for DXA monitoring.29PubMed Central. Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy Most guidelines recommend a follow-up DXA scan one to two years after starting treatment to assess whether BMD is stable or improving.
When Fractures Have Already Happened
For vertebral compression fractures that cause significant pain and loss of height, two minimally invasive procedures can help: vertebroplasty and kyphoplasty. Both involve injecting bone cement into the collapsed vertebra. Kyphoplasty uses a balloon to first restore some of the lost vertebral height before injecting cement. In one study, about 90% of acute fractures and 87% of chronic fractures had pain relief within two weeks of kyphoplasty, and vertebral body height improved significantly in both groups.30PubMed. Acute versus chronic vertebral compression fractures treated with kyphoplasty: early results Acute fractures responded better to height restoration than chronic ones, which makes sense given that chronic fractures have already partially healed in their collapsed shape.
These procedures address pain and deformity from a specific fracture, but they do not treat the underlying osteoporosis. Without systemic therapy, adjacent vertebrae remain at risk. The economic data reinforces why prevention matters: the cost of managing severe osteoporotic fractures in France alone was about €1.26 billion per year, with most of the long-term expense driven by treating repeat fractures rather than the initial break.31PubMed Central. The Economic Burden of Severe Osteoporotic Fractures in the French Healthcare Database: The FRACTOS Study Treatment after a first fracture is not optional — it is where the greatest cost and suffering can be prevented.